Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited to develop, manufacture, and commercialize antibodies that targets SRF813; and license agreement with Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Surface Oncology Inc..
Surface Oncology Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Surface Oncology Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Surface Oncology Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Surface Oncology Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Surface Oncology Inc. and all latest updates of the company are provided.
The 2025 version of Surface Oncology Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Surface Oncology Inc.- Key Facts
2.2 Surface Oncology Inc.- Geographic Locations
2.3 Surface Oncology Inc.- Subsidiaries and Affiliates
2.4 Surface Oncology Inc.- Business Divisions
2.5 Surface Oncology Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Surface Oncology Inc. Strategic Analysis Review
3.1 Surface Oncology Inc.- Key Strategies
3.2 Surface Oncology Inc.- Company Outlook Statement
3.3 Surface Oncology Inc.- SWOT Analysis
3.3.1 Surface Oncology Inc.- Key Strengths
3.3.2 Surface Oncology Inc.- Key Weaknesses
3.3.3 Surface Oncology Inc.- Potential Opportunities
3.3.4 Surface Oncology Inc.- Potential Threats
3.4 Surface Oncology Inc.- Key Competitors
4. Business Description of the Company
4.1 Surface Oncology Inc.- Business Overview
4.2 Surface Oncology Inc.- Operations by Segment
5 Products and Services Details
5.1 Surface Oncology Inc.- Key Products
5.2 Surface Oncology Inc.- Key Service Areas
5.3 Surface Oncology Inc.- Key Brands
6 Company Developments
6.1 Surface Oncology Inc.- Company History
6.2 Surface Oncology Inc.- Latest Developments
7 Financial Analysis
7.1 Surface Oncology Inc.- Income Statements
7.2 Surface Oncology Inc.- Balance Sheet
7.3 Surface Oncology Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Surface Oncology Inc.- Direct Competitors
8.2 Surface Oncology Inc.- Competitor Financial Ratios comparison
8.3 Surface Oncology Inc.- Competitor Stock Charts Comparison
8.4 Surface Oncology Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!